RecruitingPhase 4NCT07034677
Treatment With Indapamide in Patients With Post-Surgical Hypoparathyroidism
Sponsor
Lars Rejnmark
Enrollment
24 participants
Start Date
Aug 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The aim of this study is to investigate the effect of daily treatment with Indapamide for 14 days on urinary calcium excretion in patients with post surgical hypoparathyroidisme.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Indapamide 1.5 MG SR and a drug called Placebo for people with hypoparathyroidism post-surgical. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGIndapamide 1.5 MG SR
14 days treatment with indapamide 1.5 mg/day compared to placebo
DRUGPlacebo
14 days treatment with placebo
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07034677
Related Trials
PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After Thyroid Surgery"
NCT074916011 location
Parathyroid Allotransplant for Treatment of Hypoparathyroidism
NCT069610711 location
Comparing PTeye-assisted Versus Conventional Total Thyroidectomy
NCT074161491 location
PTeye vs Surgeons Eyes in Intraoperative Identification and Functional Preservation of Parathyroid Glands During Thyroid Surgery: A Parallel Randomized Controlled Clinical Trial.
NCT067659411 location